Positional scanning-synthetic peptide library-based analysis of self- and pathogen-derived peptide cross-reactivity with tumor-reactive Melan-A-specific CTL
- PMID: 12421949
- DOI: 10.4049/jimmunol.169.10.5696
Positional scanning-synthetic peptide library-based analysis of self- and pathogen-derived peptide cross-reactivity with tumor-reactive Melan-A-specific CTL
Abstract
Synthetic combinatorial peptide libraries in positional scanning format (PS-SCL) have recently emerged as a useful tool for the analysis of T cell recognition. This includes identification of potentially cross-reactive sequences of self or pathogen origin that could be relevant for the understanding of TCR repertoire selection and maintenance, as well as of the cross-reactive potential of Ag-specific immune responses. In this study, we have analyzed the recognition of sequences retrieved by using a biometric analysis of the data generated by screening a PS-SCL with a tumor-reactive CTL clone specific for an immunodominant peptide from the melanocyte differentiation and tumor-associated Ag Melan-A. We found that 39% of the retrieved peptides were recognized by the CTL clone used for PS-SCL screening. The proportion of peptides recognized was higher among those with both high predicted affinity for the HLA-A2 molecule and high predicted stimulatory score. Interestingly, up to 94% of the retrieved peptides were cross-recognized by other Melan-A-specific CTL. Cross-recognition was at least partially focused, as some peptides were cross-recognized by the majority of CTL. Importantly, stimulation of PBMC from melanoma patients with the most frequently recognized peptides elicited the expansion of heterogeneous CD8(+) T cell populations, one fraction of which cross-recognized Melan-A. Together, these results underline the high predictive value of PS-SCL for the identification of sequences cross-recognized by Ag-specific T cells.
Similar articles
-
Impact of orthologous melan-A peptide immunizations on the anti-self melan-A/HLA-A2 T cell cross-reactivity.J Immunol. 2006 Jun 1;176(11):6560-7. doi: 10.4049/jimmunol.176.11.6560. J Immunol. 2006. PMID: 16709813
-
Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.J Immunol. 1998 Feb 15;160(4):1750-8. J Immunol. 1998. PMID: 9469433
-
Overlapping peptides of melanocyte differentiation antigen Melan-A/MART-1 recognized by autologous cytolytic T lymphocytes in association with HLA-B45.1 and HLA-A2.1.Int J Cancer. 1998 Jan 30;75(3):451-8. doi: 10.1002/(sici)1097-0215(19980130)75:3<451::aid-ijc20>3.0.co;2-a. Int J Cancer. 1998. PMID: 9455808
-
Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma.Immunol Rev. 2002 Oct;188:81-96. doi: 10.1034/j.1600-065x.2002.18808.x. Immunol Rev. 2002. PMID: 12445283 Review.
-
Recognition of melanoma-derived antigens by CTL: possible mechanisms involved in down-regulating anti-tumor T-cell reactivity.Crit Rev Immunol. 1998;18(1-2):55-63. doi: 10.1615/critrevimmunol.v18.i1-2.70. Crit Rev Immunol. 1998. PMID: 9419448 Review.
Cited by
-
Synthetic α-conotoxin mutants as probes for studying nicotinic acetylcholine receptors and in the development of novel drug leads.Toxins (Basel). 2010 Jun;2(6):1471-99. doi: 10.3390/toxins2061471. Epub 2010 Jun 14. Toxins (Basel). 2010. PMID: 22069647 Free PMC article. Review.
-
Population-level distribution and putative immunogenicity of cancer neoepitopes.BMC Cancer. 2018 Apr 13;18(1):414. doi: 10.1186/s12885-018-4325-6. BMC Cancer. 2018. PMID: 29653567 Free PMC article.
-
Antibodies specific for disease-associated antigens (DAA) expressed in non-malignant diseases reveal potential new tumor-associated antigens (TAA) for immunotherapy or immunoprevention.Semin Immunol. 2020 Feb;47:101394. doi: 10.1016/j.smim.2020.101394. Epub 2020 Apr 6. Semin Immunol. 2020. PMID: 32273212 Free PMC article. Review.
-
Functional CRISPR screens in T cells reveal new opportunities for cancer immunotherapies.Mol Cancer. 2024 Apr 5;23(1):73. doi: 10.1186/s12943-024-01987-z. Mol Cancer. 2024. PMID: 38581063 Free PMC article. Review.
-
Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells.Front Oncol. 2022 Jun 30;12:912639. doi: 10.3389/fonc.2022.912639. eCollection 2022. Front Oncol. 2022. PMID: 35847919 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous